Hepatocarcinoma y trasplante hepático en Perú: resultados de 15 años del Departamento de Trasplantes del Hospital Nacional Guillermo Almenara Irigoyen - EsSalud

Omar Mantilla Cruzatti; José Carlos Chaman Ortiz; Carlos Felix Rondon Leyva; Pedro Martin Padilla MacHaca; José Rivera Romani; Bertha Cardenas Ramirez

Hepatocarcinoma y trasplante hepático en Perú: resultados de 15 años del Departamento de Trasplantes del Hospital Nacional Guillermo Almenara Irigoyen - EsSalud

Translated title of the contribution: Liver transplant and hepatocellular carcinoma in Peru: outcome after 15 years in the transplant department of the Guillermo Almenara Hospital - EsSalud

Omar Mantilla Cruzatti, José Carlos Chaman Ortiz, Carlos Felix Rondon Leyva, Pedro Martin Padilla MacHaca, José Rivera Romani, Bertha Cardenas Ramirez

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Hepatocellular carcinoma (HCC) is a neoplasm with significant incidence and prevalence in the world. In large percentage it originates from a cirrhotic liver. Liver transplantation under special conditions is effective in the simultaneous treatment of both conditions. Information is scarce in Latin America. This is a cross-sectional study of the first 200 liver transplants of our series (Years 2000-2015). During this period, 26 (13%) patients had a diagnosis of HCC. Of the 26 transplanted with HCC, 21 (81%) patients were male. The average age was 59.7 years. The most frequent cirrhotic etiology was NASH with nine (35%) cases, followed by HCV and OH with six (23%). The average of AFP pre-transplant was 113.3. Downstaging was performed in four patients. The overall survival obtained is 90.9% over 5 years. The recurrence-free survival in our series is 95.5% at 5 years.

Translated title of the contribution	Liver transplant and hepatocellular carcinoma in Peru: outcome after 15 years in the transplant department of the Guillermo Almenara Hospital - EsSalud
Original language	Spanish
Pages (from-to)	234-241
Number of pages	8
Journal	Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru
Volume	38
Issue number	3
State	Published - 1 Jul 2018
Externally published	Yes

Cite this

Mantilla Cruzatti, O., Chaman Ortiz, J. C., Rondon Leyva, C. F., Padilla MacHaca, P. M., Rivera Romani, J., & Cardenas Ramirez, B. (2018). Hepatocarcinoma y trasplante hepático en Perú: resultados de 15 años del Departamento de Trasplantes del Hospital Nacional Guillermo Almenara Irigoyen - EsSalud. Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru, 38(3), 234-241.

Mantilla Cruzatti, Omar ; Chaman Ortiz, José Carlos ; Rondon Leyva, Carlos Felix et al. / Hepatocarcinoma y trasplante hepático en Perú : resultados de 15 años del Departamento de Trasplantes del Hospital Nacional Guillermo Almenara Irigoyen - EsSalud. In: Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru. 2018 ; Vol. 38, No. 3. pp. 234-241.

@article{8c1cc0ab5cb54579ad935d06769d9447,

title = "Hepatocarcinoma y trasplante hep{\'a}tico en Per{\'u}: resultados de 15 a{\~n}os del Departamento de Trasplantes del Hospital Nacional Guillermo Almenara Irigoyen - EsSalud",

abstract = "Hepatocellular carcinoma (HCC) is a neoplasm with significant incidence and prevalence in the world. In large percentage it originates from a cirrhotic liver. Liver transplantation under special conditions is effective in the simultaneous treatment of both conditions. Information is scarce in Latin America. This is a cross-sectional study of the first 200 liver transplants of our series (Years 2000-2015). During this period, 26 (13%) patients had a diagnosis of HCC. Of the 26 transplanted with HCC, 21 (81%) patients were male. The average age was 59.7 years. The most frequent cirrhotic etiology was NASH with nine (35%) cases, followed by HCV and OH with six (23%). The average of AFP pre-transplant was 113.3. Downstaging was performed in four patients. The overall survival obtained is 90.9% over 5 years. The recurrence-free survival in our series is 95.5% at 5 years.",

author = "{Mantilla Cruzatti}, Omar and {Chaman Ortiz}, {Jos{\'e} Carlos} and {Rondon Leyva}, {Carlos Felix} and {Padilla MacHaca}, {Pedro Martin} and {Rivera Romani}, Jos{\'e} and {Cardenas Ramirez}, Bertha",

note = "Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine",

year = "2018",

month = jul,

day = "1",

language = "Espa{\~n}ol",

volume = "38",

pages = "234--241",

journal = "Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru",

issn = "1022-5129",

publisher = "Sociedad de Gastroenterologia del Peru",

number = "3",

}

Mantilla Cruzatti, O, Chaman Ortiz, JC, Rondon Leyva, CF, Padilla MacHaca, PM, Rivera Romani, J & Cardenas Ramirez, B 2018, 'Hepatocarcinoma y trasplante hepático en Perú: resultados de 15 años del Departamento de Trasplantes del Hospital Nacional Guillermo Almenara Irigoyen - EsSalud', Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru, vol. 38, no. 3, pp. 234-241.

Hepatocarcinoma y trasplante hepático en Perú: resultados de 15 años del Departamento de Trasplantes del Hospital Nacional Guillermo Almenara Irigoyen - EsSalud. / Mantilla Cruzatti, Omar; Chaman Ortiz, José Carlos; Rondon Leyva, Carlos Felix et al.
In: Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru, Vol. 38, No. 3, 01.07.2018, p. 234-241.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Hepatocarcinoma y trasplante hepático en Perú

T2 - resultados de 15 años del Departamento de Trasplantes del Hospital Nacional Guillermo Almenara Irigoyen - EsSalud

AU - Mantilla Cruzatti, Omar

AU - Chaman Ortiz, José Carlos

AU - Rondon Leyva, Carlos Felix

AU - Padilla MacHaca, Pedro Martin

AU - Rivera Romani, José

AU - Cardenas Ramirez, Bertha

N1 - Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Hepatocellular carcinoma (HCC) is a neoplasm with significant incidence and prevalence in the world. In large percentage it originates from a cirrhotic liver. Liver transplantation under special conditions is effective in the simultaneous treatment of both conditions. Information is scarce in Latin America. This is a cross-sectional study of the first 200 liver transplants of our series (Years 2000-2015). During this period, 26 (13%) patients had a diagnosis of HCC. Of the 26 transplanted with HCC, 21 (81%) patients were male. The average age was 59.7 years. The most frequent cirrhotic etiology was NASH with nine (35%) cases, followed by HCV and OH with six (23%). The average of AFP pre-transplant was 113.3. Downstaging was performed in four patients. The overall survival obtained is 90.9% over 5 years. The recurrence-free survival in our series is 95.5% at 5 years.

AB - Hepatocellular carcinoma (HCC) is a neoplasm with significant incidence and prevalence in the world. In large percentage it originates from a cirrhotic liver. Liver transplantation under special conditions is effective in the simultaneous treatment of both conditions. Information is scarce in Latin America. This is a cross-sectional study of the first 200 liver transplants of our series (Years 2000-2015). During this period, 26 (13%) patients had a diagnosis of HCC. Of the 26 transplanted with HCC, 21 (81%) patients were male. The average age was 59.7 years. The most frequent cirrhotic etiology was NASH with nine (35%) cases, followed by HCV and OH with six (23%). The average of AFP pre-transplant was 113.3. Downstaging was performed in four patients. The overall survival obtained is 90.9% over 5 years. The recurrence-free survival in our series is 95.5% at 5 years.

UR - http://www.scopus.com/inward/record.url?scp=85058593835&partnerID=8YFLogxK

M3 - Artículo

C2 - 30540726

AN - SCOPUS:85058593835

SN - 1022-5129

VL - 38

SP - 234

EP - 241

JO - Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru

JF - Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru

IS - 3

ER -

Mantilla Cruzatti O, Chaman Ortiz JC, Rondon Leyva CF, Padilla MacHaca PM, Rivera Romani J, Cardenas Ramirez B. Hepatocarcinoma y trasplante hepático en Perú: resultados de 15 años del Departamento de Trasplantes del Hospital Nacional Guillermo Almenara Irigoyen - EsSalud. Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru. 2018 Jul 1;38(3):234-241.

Hepatocarcinoma y trasplante hepático en Perú: resultados de 15 años del Departamento de Trasplantes del Hospital Nacional Guillermo Almenara Irigoyen - EsSalud

Abstract

Other files and links

Fingerprint

Cite this